Susan Martin
Psychiatric/Mental Health · Scarborough, MENPI 1285773135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 285 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$791
- AbbVie$732
- Otsuka America Pharmaceutical, Inc.$722
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$682
- Takeda Pharmaceuticals U.S.A., Inc.$581
- Axsome Therapeutics, Inc.$578
- plus $2K from 11 others
What the payments were for
- Food & beverage$6,338100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 46 | $791 |
| AbbVie | 36 | $732 |
| Otsuka America Pharmaceutical, Inc. | 41 | $722 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $682 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $581 |
| Axsome Therapeutics, Inc. | 17 | $578 |
| Neurocrine Biosciences, Inc. | 25 | $481 |
| Johnson & Johnson | 9 | $407 |
| Lundbeck LLC | 15 | $388 |
| Teva Pharmaceuticals USA, Inc. | 9 | $342 |
| Corium, LLC | 12 | $268 |
| Sunovion Pharmaceuticals Inc. | 7 | $153 |
| Collegium Pharmaceutical, Inc. | 4 | $90 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Merck | 2 | $40 |
| Indivior Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$339
- Auvelity$256
- SPRAVATO$230
- Austedo XR$125
- VRAYLAR$100
How this compares
$6,338 in reported general payments places this provider in the 95th percentile of 192 psychiatric/mental health providers in Maine.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 36 | $2,142 |
| Bupropion XlBupropion Hcl | 21 | $1,041 |
| Gabapentin | 16 | $386 |
| Escitalopram Oxalate | 16 | $354 |
| Clonazepam | 27 | $117 |
| Zolpidem Tartrate | 19 | $35 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Scarborough
- Marianne TarrazaScarborough$22K
- Samuel KingsleyScarborough$6K
- Alison CameronScarborough$5K
- Micah MalenfantScarborough$3K
- Donna ChamoffScarborough$2K
- Mark ShaughnessyScarborough$845
- Ellie FlemingScarborough$405
- Kelly BraggMadison$21K
- Larry SextonAugusta$15K
- Michelle ChmeleckiPortland$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.